Nektar Therapeutics ( NKTR) - Key Metrics
NKTR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.07 | -$1.78 | -$3.20 | -$3.20 |
| 2025Q3 | $0.84 | -$2.52 | -$3.46 | -$3.47 |
| 2025Q2 | $0.79 | -$2.95 | -$3.25 | -$3.25 |
| 2025Q1 | $0.74 | -$3.62 | -$3.49 | -$3.49 |
NKTR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -5.95 |
| 2025Q3 | ? | -5.64 |
| 2025Q2 | ? | -2.19 |
| 2025Q1 | ? | -0.70 |
NKTR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -2.49% | ? |
| 2025Q4 | -7.57% | ? |
| 2025Q3 | -6.10% | ? |
| 2025Q2 | -12.57% | ? |
| 2025Q1 | -34.20% | ? |
NKTR
Price: $70.72
52 week price:
Payout Ratio Range:
Earnings Per Share: -7.93 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.8 million
Ebitda: 74.9 millionMarket Capitalization: 1.4 billion